HomeInsights
INDUSTRY:
Pharma
TOPIC:
Regulatory & Legal
TITLE:
EMA: CHMP adopted a positive opinion for Intrarosa (prasterone) 6.5 mg pessary from Endoceutics Ltd.
BRIEF:
EMA: CHMP adopted a positive opinion for Intrarosa (prasterone) 6.5 mg pessary from Endoceutics Ltd. Intrarosa is intended for the treatment of vulvar and vaginal atrophy in postmenopausal women having moderate to severe symptoms. (ATC code: to be determined). The EC Decision will follow soon.
LEGAL IMPLICATIONS:
BUSINESS IMPLICATIONS:
